Literature DB >> 3540079

Impaired insulin response to glucose but not to arginine in heroin addicts.

N Passariello, D Giugliano, A Ceriello, A Chiariello, S Sgambato, F D'Onofrio.   

Abstract

Plasma glucose, insulin, glucagon and growth hormone responses to both oral glucose and iv arginine were evaluated in 15 heroin addicts and 15 control subjects matched for age, sex and weight. The heroin users had an exaggerated rise in plasma glucose concentrations following oral sugar, which persisted until the end of the study (102 +/- 5 mg/dl in addicts vs 72 +/- 3 mg/dl in controls at 240 min, p less than 0.01) and significantly lower insulin responses (insulin peak 28 +/- 4 microU/ml in addicts vs 67 +/- 8 microU/ml in controls, p less than 0.01). The inhibitory effect of glucose on glucagon concentrations was less evident in addicts than in controls. The responses of plasma glucose, insulin and glucagon to arginine were not significantly different between addicts and controls, while the growth hormone rise was significantly greater in addicts. These results demonstrate that heroin users have impaired insulin secretion to oral glucose but not to arginine and suggest that: the impaired insulin secretion in heroin addicts is not dependent on beta-cell exhaustion, and a selective inhibition of glucose-induced insulin secretion is operative in these subjects, as it happens in patients with noninsulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3540079     DOI: 10.1007/BF03346942

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  25 in total

1.  Oral glucose tolerance and hormonal response in heroin-dependent males.

Authors:  J L Reed; A H Ghodse
Journal:  Br Med J       Date:  1973-06-09

2.  Inhibition of gastric emptying by enkephalin analogue.

Authors:  S N Sullivan; L Lamki; P Corcoran
Journal:  Lancet       Date:  1981-07-11       Impact factor: 79.321

3.  Endogenous opiates, heroin addiction, and non-insulin-dependent diabetes.

Authors:  D Giugliano; A Ceriello; A Quatraro; F D'Onofrio
Journal:  Lancet       Date:  1985-10-05       Impact factor: 79.321

4.  Increased glycosylated proteins in opiate addicts.

Authors:  A Ceriello; P Dello Russo; F Curcio; P Rossano
Journal:  Diabetes Care       Date:  1984 Jan-Feb       Impact factor: 19.112

5.  Effect of an enkephalin-analogue (FK 33-824) on glucose tolerance in man.

Authors:  X Jeanrenaud; E Maeder; E Del Pozo; J P Felber
Journal:  Acta Endocrinol (Copenh)       Date:  1983-09

6.  Glucose tolerance in opiate addicts.

Authors:  P P Vescovi; A Pezzarossa; R Caccavari; G Valenti; U Butturini
Journal:  Diabetologia       Date:  1982-11       Impact factor: 10.122

7.  Impaired insulin secretion in human diabetes mellitus. The effect of naloxone-induced opiate receptor blockade.

Authors:  D Giugliano; A Ceriello; P di Pinto; F Saccomanno; S Gentile; F Cappiapuoti
Journal:  Diabetes       Date:  1982-04       Impact factor: 9.461

8.  Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.

Authors:  J P Palmer; J W Benson; R M Walter; J W Ensinck
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

9.  beta-Endorphin in the human pancreas.

Authors:  J F Bruni; W B Watkins; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1979-10       Impact factor: 5.958

10.  Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus.

Authors:  D Giugliano; T Salvatore; D Cozzolino; A Ceriello; R Torella; F D'Onofrio
Journal:  J Clin Endocrinol Metab       Date:  1987-06       Impact factor: 5.958

View more
  7 in total

1.  Health conditions among aging narcotics addicts: medical examination results.

Authors:  Yih-Ing Hser; Lillian Gelberg; Valerie Hoffman; Christine E Grella; William McCarthy; M Douglas Anglin
Journal:  J Behav Med       Date:  2004-12

Review 2.  Aging and HIV infection.

Authors:  Rakhi Kohli; Robert S Klein; Ellie E Schoenbaum; Kathryn Anastos; Howard Minkoff; Henry S Sacks
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

Review 3.  Opioid peptides and metabolic regulation.

Authors:  D Giugliano; R Torella; P J Lefèbvre; F D'Onofrio
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

4.  Sodium salicylate restores the impaired insulin response to glucose and improves glucose tolerance in heroin addicts.

Authors:  D Giugliano; A Quatraro; G Consoli; A Stante; V Simeone; A Ceriello; G Paolisso; R Torella
Journal:  Acta Diabetol Lat       Date:  1987 Jul-Sep

5.  Disorders of glucose metabolism among HIV-infected women.

Authors:  Andrea A Howard; Michelle Floris-Moore; Julia H Arnsten; Nanette Santoro; Norman Fleischer; Yungtai Lo; Ellie E Schoenbaum
Journal:  Clin Infect Dis       Date:  2005-04-11       Impact factor: 9.079

6.  What are the characteristics of vitamin D metabolism in opioid dependence? An exploratory longitudinal study in Australian primary care.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  BMJ Open       Date:  2018-01-13       Impact factor: 2.692

7.  Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone.

Authors:  Igor Elman; Margaret Howard; Jacob T Borodovsky; David Mysels; David Rott; David Borsook; Mark Albanese
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.